RESUMO
Background: Autotaxin-lysophosphatidic acid (ATX-LPA) signaling has a predominant role in immunological and fibrotic processes, including cancer. Several ATX inhibitors and LPA receptor antagonists have been clinically evaluated, but none in patients with solid tumors. Many cancers are burdened with a high degree of fibrosis and an immune desert phenotype (so-called 'cold' tumors). In these cold tumors, the fibrotic stroma provides an intrinsic cancer-supporting mechanism. Furthermore, the stroma prevents penetration and limits the effectiveness of existing therapies. IOA-289 is a novel ATX inhibitor with a unique chemical structure, excellent potency and an attractive safety profile. Materials and methods: In vitro and in vivo pharmacology studies have been carried out to elucidate the pharmaceutical properties and mechanism of action of IOA-289. A phase I clinical study in healthy volunteers was carried out to determine the pharmacokinetics and pharmacodynamics of IOA-289 following a single oral dose. Results: In vitro and in vivo studies showed that IOA-289 is a potent inhibitor of ATX and, as a monotherapy, is able to slow progression of lung fibrosis and tumor growth in mouse models. In a clinical study, IOA-289 showed a dose-dependent increase in plasma exposure levels and a corresponding decrease in circulating LPA. Conclusions: Our data show that IOA-289 is a novel ATX inhibitor with a unique chemical structure, excellent potency and an attractive safety profile. Our data support the further development of IOA-289 as a novel therapeutic approach for the treatment of cancer, particularly those with a high fibrotic and immunologically cold phenotype.
RESUMO
The authors present a computer analysis of 315 fractures of the proximal end of the femur. The data were placed in an M24 computer which had previously been programmed for a recording of traumatological cases. Unstable pertrochanteric fractures are discussed in particular, as well as the results obtained in relation to the type of osteosynthesis used.
Assuntos
Fraturas do Colo Femoral/classificação , Fraturas do Quadril/classificação , Prontuários Médicos , Computadores , Fraturas do Colo Femoral/terapia , Fixação Interna de Fraturas/métodos , Fraturas do Quadril/terapia , Humanos , Dispositivos de Fixação OrtopédicaRESUMO
Two cases of bronchial carcinoma with cutaneous metastasis are reported with emphasis on the rarity of the event, the clinical and histological aspects and the prognosis for such metastases.